was used to build a gene tree and reconcile it with the species tree. TreeBest builds five source trees using nj and Phyml 2 , and then merges them into one tree while attempting to minimise the number of duplications using a species tree. N/A (not applicable) indicates no gene name but it exists in the species with accession numbers for reference. treated with thapsigargin (Tg; 1 µM) and tunicamycin (Tm; 3 µg/ml) for the time periods as indicated. Total RNAs were reverse-transcribed and measured by TaqMan-based real-time PCR assay using the delta-delta Ct method. Data are normalized to the amount of GAPDH; results are expressed as the fold increase compared with control (mean ± SD; n = 4). Statistical analysis was performed with ANOVA followed by Bonferroni correction (vs. control; *p < 0.05, **p < 0.01, ***p < 0.001). Expression of RNF128, ZNRF4, RNF175, RNF152 and RNF180 was not detected in HeLa cells because their levels were below the detection limit. and incubated for 42 h. The cells were stained with crystal violet. The eluted dye at an optical density of 590 nm was measured. Cell viability was calculated as follows: OD for assay/OD for control well.
SUPPLEMENTARY REFERENCES
The results are expressed as the fold increase compared with normal cells. The results are expressed as the means ± SD (three independent experiments in duplicate). Statistical analysis was performed with ANOVA followed by Bonferroni correction (vs. controls; *p < 0.05, **p < 0.01) (b) In vitro autoubiquitination assay. The RNF145 proteins produced by a transcription/translation system were mixed in the reaction buffer with E1 (rabbit), E2 (GST-UbcH5c) and GST-ubiquitin. The reaction mixture was immunoprecipitated with anti-V5 antibody and analysed by Western blotting using anti-GST antibody. CS mutants defective in E3 activity were constructed by replacement of conserved coordinating Cys with Ser residues in the RING (c) Subcellular localization of RNF145.
COS-1 cells transiently transfected with RNF145-V5. The cells were subjected to immunofluorescence staining with anti-V5 and calreticulin antibodies. 
